Assay News and Research

RSS

Depression reduces efficacy of shingles vaccine

Research suggests that the varicella zoster, or shingles, vaccine is less effective in older people with untreated depression.

15 Feb 2013

Protein test may help identify bacterial COPD exacerbations

Increased serum levels of pancreatic stone protein/regenerating protein may help identify bacteria-related exacerbations of chronic obstructive pulmonary disease, say researchers.

15 Feb 2013

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

TB is an infectious disease caused by Mycobacterium tuberculosis. Nearly 9 million people develop TB every year, and TB kills nearly 1.4 million individuals each year. While the incidence of TB has steadily declined in the west, it remains a huge public health problem in many developing countries, with India having the highest burden.

15 Feb 2013

SQI Diagnostics reports net loss of $1,563,000 for quarter-ended December 31, 2012

SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.

15 Feb 2013

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Viracor-IBT Laboratories, Inc. announced today that it has signed a definitive agreement to purchase the assets of Cylex, Inc., a global life sciences company focused on the development, manufacturing and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine.

5 Feb 2013

MammaPrint breast cancer test can help women avoid chemotherapy

The MammaPrint breast cancer test can dramatically reduce the number of women who need to undergo chemotherapy to treat the disease, according to a newly published study.

5 Feb 2013

AIBioTech announces implementation of L-asparaginase activity assay for pediatric ALL

AIBioTech is pleased to announce implementation of a new laboratory derived test to measure L-asparaginase levels in patients being treated with any of the current asparaginase drugs including: Oncaspar, Kidrolase, Erwinaze, and Elspar.

5 Feb 2013

Luminex consolidated fourth quarter revenue increases 16% to $55.5 million

Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2012.

From Luminex 4 Feb 2013

FDA approves Biotest's BIVIGAM to treat Primary Humoral Immunodeficiency

Biotest Pharmaceuticals Corporation (BPC), a wholly owned U.S. subsidiary of Biotest AG, recently announced the U.S. Food and Drug Administration's (FDA) approval of BIVIGAM, its new intravenous immune globulin, for the treatment of patients with Primary Humoral Immunodeficiency (PI).

31 Jan 2013

Genzyme receives FDA approval for Kynamro to treat homozygous familial hypercholesterolemia

The U.S. Food and Drug Administration today approved Kynamro (mipomersen sodium) injection as an addition to lipid-lowering medications and diet to treat patients with a rare type of high cholesterol called homozygous familial hypercholesterolemia (HoFH).

30 Jan 2013

Dectin-1 potential target for nasal polyposis

The transmembrane protein Dectin-1 appears to play a role in the pathogenesis of nasal polyposis, providing a potential new target for treating the condition, report Chinese researchers.

29 Jan 2013

Apelin-12 levels increased in childhood asthma

Children with asthma demonstrate significantly increased serum levels of the adipokine apelin-12, researchers report.

25 Jan 2013

Vejthani ART Center provides innovative and high quality services

Vejthani Hospital Bangkok recommends Assisted Reproductive Technology Center at Vejthani ART Center, the way to bring your dream come true that you will be assured by our professional service.

25 Jan 2013

New study may help treat patients with multiple myeloma

A study led by Robert G. Hawley, Ph.D., professor and chair of the department of anatomy and regenerative biology at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), may help predict which patients with multiple myeloma will respond better to certain treatments.

25 Jan 2013

Study may help predict which multiple myeloma patients will respond better to certain treatments

24 Jan 2013

SV Bio, Mayo Clinic partner on whole genome diagnostics and interpretation

Mayo Clinic and Silicon Valley Biosystems (SV Bio) today announced a strategic collaboration for whole genome diagnostics and interpretation at the Mayo Clinic Center for Individualized Medicine and Mayo Medical Laboratories.

23 Jan 2013

New details about molecular surveillance system that helps detect and correct errors in cell division

Studies led by cell biologist Thomas Maresca at the University of Massachusetts Amherst are revealing new details about a molecular surveillance system that helps detect and correct errors in cell division that can lead to cell death or human diseases. Findings are reported in the current issue of the Journal of Cell Biology.

21 Jan 2013

Life Technologies, ASU partner on new project to quickly measure radiation exposure

Arizona State University's Biodesign Institute- has announced a partnership with Life Technologies Corporation as it enters the next phase of a multi-million-dollar, multi-institutional research project to develop a medical device to rapidly assess an individual's exposure to radiation in the event of a nuclear incident.

18 Jan 2013

Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Thermo Scientific QMS Everolimus Assay Kit has been CE marked for sale in the European Union for a third application, namely liver transplants.

From Thermo Fisher Scientific Inc. 16 Jan 2013

FDA clears Hologic's APTIMA Trichomonas vaginalis Assay

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has cleared for marketing its APTIMA Trichomonas vaginalis Assay on the Company's fully-automated PANTHER System.

From Hologic, Inc. 15 Jan 2013

Assay News and Research

Depression reduces efficacy of shingles vaccine

Protein test may help identify bacterial COPD exacerbations

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

SQI Diagnostics reports net loss of $1,563,000 for quarter-ended December 31, 2012

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

MammaPrint breast cancer test can help women avoid chemotherapy

AIBioTech announces implementation of L-asparaginase activity assay for pediatric ALL

Luminex consolidated fourth quarter revenue increases 16% to $55.5 million

FDA approves Biotest's BIVIGAM to treat Primary Humoral Immunodeficiency

Genzyme receives FDA approval for Kynamro to treat homozygous familial hypercholesterolemia

Dectin-1 potential target for nasal polyposis

Apelin-12 levels increased in childhood asthma

Vejthani ART Center provides innovative and high quality services

New study may help treat patients with multiple myeloma

Study may help predict which multiple myeloma patients will respond better to certain treatments

SV Bio, Mayo Clinic partner on whole genome diagnostics and interpretation

New details about molecular surveillance system that helps detect and correct errors in cell division

Life Technologies, ASU partner on new project to quickly measure radiation exposure

Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application

FDA clears Hologic's APTIMA Trichomonas vaginalis Assay

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News